MMT (Momentum) 24-hour amplitude reaches 76.2%: Trading volume surges nearly $100 million, triggering intense volatility
Bitget Pulse2026/04/05 18:25Volatility Brief
In the past 24 hours, the price of MMT soared from a low of $0.1107 to a peak of $0.195, with the current price at $0.1383, marking a fluctuation amplitude of 76.2%. Supplementary data includes an impressive 24-hour trading volume ranging from $98.14 million (CoinGecko) to $122.81 million (CoinMarketCap), far exceeding the market cap of approximately $28 million, indicating extremely high turnover.
Analysis of Abnormal Activity Causes
- Abnormally High Trading Volume: 24-hour trading volume reached $98–122 million, several times higher than normal, propelling the price from a low of $0.1111 to highs between $0.1688 and $0.1772, followed by a slight pullback.
- Increased Community Activity: Discord mentions of $MMT reached 27 times, ranking among the top five in the excitement list; the official X account @MMTFinance posted on April 4 that March Swap volume ranked in the top ten on Sui, indirectly drawing attention.
No official announcements, listings, or on-chain whale large movements have been recorded as direct events.
Market Views and Outlook
Overall, market sentiment leans positive, with a 24-hour price increase of 23.4%–27.16%. Discord user excitement is high, and the official channels continue to emphasize development progress (such as "Building"). The high turnover rate suggests speculation is the main driver in the short term, warranting caution over increased volatility risk. No clear analyst forecasts have been observed.
Note: This analysis is automatically generated by AI based on publicly available data and on-chain monitoring, for informational purposes only.Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
AstraZeneca invests $2 billion in Summit, optimistic about Akeso's Ivose
This 18.6% premium subscription is not only a substantial endorsement, but both parties will also deeply collaborate on the joint development of combination therapies such as ADCs. The core of this deal is Akeso's Ivonescimab—the world’s first PD-1/VEGF bispecific antibody, and so far the only drug to have surpassed "K-drug" in head-to-head trials on both PFS and OS endpoints. The median OS reached 30.8 months, compared to 22.6 months for "K-drug", representing a 27% reduction in risk of death.
AMD (AMD.US) Surpasses $1 Trillion Market Cap and Begins Competing for "Computing Power Definition Rights"! Officially Announces $8.2 Billion Acquisition of Fei-Fei Li's World Labs
AMD has agreed to acquire World Labs for $8.2 billion, thereby gaining access to the artificial intelligence startup founded by industry pioneer and researcher Fei-Fei Li. This acquisition is expected to help AMD plan its future hardware launches by bringing in a team of top researchers and their models, as well as deep insights into trends in the field of artificial intelligence.
A Major Reversal Amid the U.S. Bond Selloff! Bond Market Veteran Bianco Turns Bullish for the First Time in Six Years, Calling 5% Yield a "Value Buy Opportunity"
Currently, as benchmark U.S. Treasury yields surge to their highest levels in nearly two decades, bond market veteran Jim Bianco has loosened his bearish stance for the first time and is gradually building long positions as a "value buyer."
Crypto prices
More
